Status:

COMPLETED

Efficacy of Lansoprazole in Chronic Post Nasal Drip

Lead Sponsor:

Vanderbilt University

Collaborating Sponsors:

TAP Pharmaceutical Products Inc.

Conditions:

Larynx Disease

Eligibility:

All Genders

18+ years

Phase:

PHASE3

Brief Summary

The purpose of this study is to determine whether aggressive acid suppression with Lansoprazole is effective in the treatment of post nasal drip, and also assess the predictors of response based on cl...

Detailed Description

Postnasal drip (PND) is a common complaint that brings patients to the attention of their primary care physicians. It is also one of the most common reasons for patients to seek care from otolaryngolo...

Eligibility Criteria

Inclusion

  • Negative RAST inhalant allergy panel OR negative skin testing (Group A)
  • Positive RAST or Positive skin testing AND insufficient response to all of the following: (Group B)
  • Allergen avoidance
  • Topical nasal steroids
  • Allergy shots if indicated
  • Antihistamines
  • Negative CT sinuses (coronal)
  • \< 4mm of mucosal thickening and \< 3 sinus sites
  • Absence of air-fluid levels
  • Negative anterior rhinoscopy
  • Absence of pus, crusts on mucosal surfaces

Exclusion

  • Age \< 18
  • Pregnancy, confirmed by urine pregnancy test at day of randomization
  • Ciliary dyskinesia
  • Immune deficiency
  • Cystic fibrosis
  • Diagnosis of acute sinusitis or chronic RS (AAO-HNS)
  • Active use of topical decongestant
  • Use of PPI within the last 30 days
  • Previous fundoplication
  • Uncontrolled thyroid disease
  • Isolated chronic cough without the symptom of post nasal drip

Key Trial Info

Start Date :

August 1 2006

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

December 1 2008

Estimated Enrollment :

75 Patients enrolled

Trial Details

Trial ID

NCT00335283

Start Date

August 1 2006

End Date

December 1 2008

Last Update

August 21 2012

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Vanderbilt University Medical Center, Vanderbilt Digestive Disease Clinic, TVC, Room 1660

Nashville, Tennessee, United States, 37232-5280